Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01042548|
Recruitment Status : Recruiting
First Posted : January 5, 2010
Last Update Posted : February 6, 2019
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||February 2021|
|Estimated Study Completion Date :||February 2021|
Subjects will be asked to allow us to collect an extra 2 tablespoons of blood at the time of pre-operative blood work. For those subjects with cancer who undergo surgery, a follow-up blood sample will be collected prior to chemotherapy, radiation, or hormonal therapy, and every six months afterwards at the time of their standard clinic/office visit for two years, then once a year for year 3-5. This will allow researchers to examine the samples to determine if blood changes over time after surgery, and what type of result may indicate a risk for recurrence.
Any remaining blood samples not used for the study will remain in the laboratory for future research.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01042548
|Contact: Cathy Van Every, BSN||412-781-3744 ext firstname.lastname@example.org|
|United States, Pennsylvania|
|UPMC St. Margaret||Recruiting|
|Pittsburgh, Pennsylvania, United States, 15215|
|Contact: Cathy Van Every, BSN 412-781-3744 ext 112 email@example.com|
|Principal Investigator: Min Sun, MD, PhD|